A recent study co-authored by a Warren Alpert Medical School professor showed the effectiveness of convalescent plasma therapies for treating COVID-19 early in its disease course and preventing ...
Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...
WEST COLUMBIA, S.C. — Whether from an injury or the normal wear and tear that accompanies aging, most of us will experience musculoskeletal pain at some point. Sports medicine physician J. Clint Pride ...
- We were on a trip, and I wasn't feeling too good. I thought it was just a cold, but it felt different. We went to the emergency room, and the doctor said, "You have a very bad case of COVID. "Go ...
ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of ...
1don MSN
Engineered albumin-fused FIX extends hemophilia B treatment half-life beyond standard 3–4 day window
After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in ...
PHILADELPHIA (CBS) -- Running injuries are common. Many on Broad Street this weekend will be dealing with a variety of aches and pains. One emerging treatment involves using the patient's own blood.
ADMA Biologics ADMA and Grifols GRFS are leading producers of plasma-derived therapies, specializing in immunoglobulin treatments for immunodeficiencies and other conditions. ADMA Biologics markets ...
Hydrophobic surfaces show low surface energy, so water droplets tend to repel against the surface and create beads that form a spherical droplet with a high water contact angle (>90°). Surfaces can be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results